Status:

COMPLETED

Preoperative Cisplatin in Early Stage Breast Cancer

Lead Sponsor:

Dana-Farber Cancer Institute

Collaborating Sponsors:

Beth Israel Deaconess Medical Center

Massachusetts General Hospital

Conditions:

Breast Cancer

Eligibility:

All Genders

18+ years

Phase:

PHASE2

Brief Summary

The purpose of this study is to find out what effects the preoperative therapy cisplatin will have on patients with early stage estrogen receptor-negative (ER-), progesterone receptor-negative (PR-), ...

Detailed Description

Before starting treatment patients will undergo placement of a clip into the tumor bed so the surgeon can locate the site of the tumor at the time of surgery. Patients will receive cisplatin intraven...

Eligibility Criteria

Inclusion

  • All tumors must be ER-, PR- and HER-2 negative.
  • Age \> 18 years
  • ECOG performance status of less than or equal to 1
  • Absolute neutrophil count (ANC) \> 1,500/mm3
  • Hemoglobin \> 9mm/dl
  • Platelets \> 100,000/mm3
  • Creatinine \< 1.5mg/dl
  • Glucose \< 200mg/dl
  • Bilirubin \< 1.5 x upper limit of normal (ULN)
  • SGOT \< 3.0 x ULN

Exclusion

  • Prior chemotherapy treatment
  • Pregnant or breast-feeding women
  • History of serious illness, medical or psychiatric condition requiring medical management
  • Uncontrolled infection
  • Renal dysfunction
  • Active or severe cardiovascular or pulmonary disease
  • Peripheral neuropathy of any etiology that exceeds grade 1
  • Prior history of malignancy
  • Uncontrolled diabetes

Key Trial Info

Start Date :

July 1 2004

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

May 1 2010

Estimated Enrollment :

27 Patients enrolled

Trial Details

Trial ID

NCT00148694

Start Date

July 1 2004

End Date

May 1 2010

Last Update

August 31 2016

Active Locations (3)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (3 locations)

1

Beth Israel Deaconess Medical Center

Boston, Massachusetts, United States, 02115

2

Dana-Farber Cancer Institute

Boston, Massachusetts, United States, 02115

3

Massachusetts General Hospital

Boston, Massachusetts, United States, 02115

Preoperative Cisplatin in Early Stage Breast Cancer | DecenTrialz